Effect of age on response to zafirlukast in patients with asthma in the Accolate clinical experience and pharmacoepidemiology trial (ACCEPT)
- 29 February 2000
- journal article
- clinical trial
- Published by Elsevier BV in Annals of Allergy, Asthma & Immunology
- Vol. 84 (2), 217-225
- https://doi.org/10.1016/s1081-1206(10)62759-7
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Two first-line therapies in the treatment of mild asthma: use of peak flow variability as a predictor of effectivenessAnnals of Allergy, Asthma & Immunology, 1999
- Zafirlukast improves asthma symptoms and quality of life in patients with moderate reversible airflow obstructionJournal of Allergy and Clinical Immunology, 1998
- Is Asthma in the Elderly Really Different?Respiration, 1998
- Zafirlukast for symptomatic mild-to-moderate asthma: a 13-week multicenter studyClinical Therapeutics, 1997
- Patient Handling of a Multidose Dry Powder Inhalation Device for AlbuterolSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 1994
- Peripheral mononuclear leucocyte beta adrenoceptors and non-specific bronchial responsiveness to methacholine in young and elderly normal subjects and asthmatic patients.Thorax, 1994
- Asthma in the Elderly: A Comparison Between Patients with Recently Acquired and Long-standing DiseaseAmerican Review of Respiratory Disease, 1991
- What determines whether an elderly patient can use a metered dose inhaler correctly?Respiratory Medicine, 1986
- Lung function in the elderly.Thorax, 1985
- Reduced β-adrenergic receptor concentrations in ageing manNature, 1977